As the 66th ASH Annual Meeting wraps up, we’re reflecting on the incredible research shared by the hematology community. Together, we are driven by one shared mission: to reimagine treatment and improve life for those impacted by blood cancer. Our passion for innovation fuels us to explore new therapeutic targets and tackle diverse disease states. With a growing hematology portfolio, we remain dedicated to getting #InFrontOfCancer. #ASH24 #JNJOncology